Wharton finance professor Jeremy Siegel expects a game changer.
He predicts a coronavirus vaccine is closer than the market thinks.
“We’ve had almost no setbacks in the schedule developing the vaccine, and I think that’s where upside surprises can occur,” Siegel told CNBC’s “Trading Nation” on Tuesday. “We may find ourselves with a workable vaccine for high risk individuals by the end of the fall, early winter.”